has been cited by the following article(s):
[1]
|
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium‐glucose cotransporter 2 inhibitors vs dipeptidyl peptidase‐4 inhibitors in Japan: A real‐world administrative database analysis
Journal of Diabetes Investigation,
2024
DOI:10.1111/jdi.14123
|
|
|
[2]
|
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium‐glucose cotransporter 2 inhibitors vs dipeptidyl peptidase‐4 inhibitors in Japan: A real‐world administrative database analysis
Journal of Diabetes Investigation,
2024
DOI:10.1111/jdi.14123
|
|
|
[3]
|
Evaluation of Medical Costs of Kidney Diseases and Risk Factors in Japan
Health,
2017
DOI:10.4236/health.2017.913127
|
|
|